Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer.
Saved in:
| Title: | Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer. |
|---|---|
| Authors: | Rencinai A; Department of Medical Biotechnology, University of Siena, Siena, Italy., Tollapi E; Department of Medical Biotechnology, University of Siena, Siena, Italy., Marianantoni G; Department of Medical Biotechnology, University of Siena, Siena, Italy., Brunetti J; Department of Medical Biotechnology, University of Siena, Siena, Italy., Henriquez T; Department of Medical Biotechnology, University of Siena, Siena, Italy., Pini A; Department of Medical Biotechnology, University of Siena, Siena, Italy., Bracci L; Department of Medical Biotechnology, University of Siena, Siena, Italy., Falciani C; Department of Medical Biotechnology, University of Siena, Siena, Italy. |
| Source: | Frontiers in molecular biosciences [Front Mol Biosci] 2024 Oct 02; Vol. 11, pp. 1429163. Date of Electronic Publication: 2024 Oct 02 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653173 Publication Model: eCollection Cited Medium: Print ISSN: 2296-889X (Print) Linking ISSN: 2296889X NLM ISO Abbreviation: Front Mol Biosci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2296-889X |
|---|---|
| DOI: | 10.3389/fmolb.2024.1429163 |
